Form 8-K - Current report:
SEC Accession No. 0001178913-25-002406
Filing Date
2025-07-18
Accepted
2025-07-18 16:29:27
Documents
13
Period of Report
2025-07-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K zk2533453.htm   iXBRL 8-K 58813
  Complete submission text file 0001178913-25-002406.txt   231326

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA entx-20250716.xsd EX-101.SCH 4793
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20250716_def.xml EX-101.DEF 17919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20250716_lab.xml EX-101.LAB 27305
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20250716_pre.xml EX-101.PRE 20104
16 EXTRACTED XBRL INSTANCE DOCUMENT zk2533453_htm.xml XML 6720
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 251134819
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)